Seminars in Hematology
Volume 41, Issue 2 , Pages 93-117 , April 2004

Red blood cell blood group antigens: structure and function

  • Marion E Reid

      Affiliations

    • Corresponding Author InformationAddress correspondence to Marion Reid, PhD, Lindsley F. Kimball Research Institute, New York Blood Center, 310 E 67th St, New York, NY 10021, USA
    • Laboratory of Immunochemistry, New York Blood Center, New York, NY, USA
    • ,
  • Narla Mohandas

      Affiliations

    • Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA

References 

  1. Garratty G, Dzik WH, Issitt PD, et al.  Terminology for blood group antigens and genes (Historical origins and guidelines in the new millennium). Transfusion. 2000;40:477–489
  2. Daniels GL, Cartron JP, Fletcher A, et al.  International Society of Blood Transfusion Committee on terminology for red cell surface antigens (Vancouver report). Vox Sang. 2003;84:244–247
  3. Lögdberg L, Reid ME, Miller JL. Cloning and genetic characterization of blood group carrier molecules and antigens. Transfus Med Rev. 2002;16:1–10
  4. In:  Hoffman R,  Benz EJ,  Shattil SJ, et al. editor. Hematology (Basic Principles and Practice). (ed 2). New York, NY: Churchill Livingstone; 1995;
  5. Alberts B, Bray D, Lewis J, et al.  Molecular Biology of the Cell. (ed 3). New York, NY: Garland; 1994;
  6. Walensky LD, Narla M, Lux SE. Disorders of the red blood cell membrane. In:  Handin RI,  Lux SE,  Stossel TP editor. Blood (Principles and Practice of Hematology). (ed 2). Philadelphia, PA: Lippincott Williams & Wilkins; 2003;p. 1709–1858
  7. Telen MJ. Erythrocyte blood group antigens (Not so simple after all). Blood. 1995;85:299–306
  8. Cartron JP, Colin Y. Structural and functional diversity of blood group antigens. Transfus Clin Biol. 2001;8:163–199
  9. Paulson JC, Colley KJ. Glycosyltransferases. Structure, localization, and control of cell type- specific glycosylation. J Biol Chem. 1989;264:17615–17618
  10. Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. (ed 10). Oxford, England: Blackwell Science; 1997;
  11. Anstee DJ, Spring FA. Red cell membrane glycoproteins with a broad tissue distribution. Transfus Med Rev. 1989;3:13–23
  12. Southcott MJG, Tanner MJ, Anstee DJ. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood. 1999;93:4425–4435
  13. Le Van Kim C, Piller V, Cartron JP, et al.  Glycophorins C and D are generated by the use of alternative translation initiation sites. Blood. 1996;88:2364–2365
  14. Cartron J-P, Le Van Kim C, Colin Y. Glycophorin C and related glycoproteins (Structure, function, and regulation). Semin Hematol. 1993;30:152–168
  15. Reid ME, Spring FA. Molecular basis of glycophorin C variants and their associated blood group antigens. Transfus Med. 1994;4:139–149
  16. Villeval JL, Le Van Kim C, Bettaieb A, et al.  Early expression of glycophorin C during normal and leukemic human erythroid differentiation. Cancer Res. 1989;49:2626–2632
  17. Chasis JA, Mohandas N. Red blood cell glycophorins. Blood. 1992;80:1869–1879
  18. Hemming NJ, Anstee DJ, Mawby WJ, et al.  Localisation of the protein 4.1-binding site on human erythrocyte glycophorins C and D. Biochem J. 1994;299:191–196
  19. Nunomura W, Takakuwa Y, Parra M, et al.  Regulation of protein 4.1R, p55, and glycophorin C ternary complex in human erythrocyte membrane. J Biol Chem. 2000;275:24540–24546
  20. Reid ME, Chasis JA, Mohandas N. Identification of a functional role for human erythrocyte sialoglycoproteins beta and gamma. Blood. 1987;69:1068–1072
  21. Reid ME, Takakuwa Y, Conboy J, et al.  Glycophorin C content of human erythrocyte membrane is regulated by protein 4.1. Blood. 1990;75:2229–2234
  22. Alloisio N, Dalla Venezia N, Rana A, et al.  Evidence that red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C. Blood. 1993;82:1323–1327
  23. Workman RF, Low PS. Biochemical analysis of potential sites for protein 4.1-mediated anchoring of the spectrin-actin skeleton to the erythrocyte membrane. J Biol Chem. 1998;273:6171–6176
  24. Hemming NJ, Anstee DJ, Staricoff MA, et al.  Identification of the membrane attachment sites for protein 4.1 in the human erythrocyte. J Biol Chem. 1995;270:5360–5366
  25. Marfatia SM, Morais-Cabral JH, Kim AC, et al.  The PDZ domain of human erythrocyte p55 mediates its binding to the cytoplasmic carboxyl terminus of glycophorin C—Analysis of the binding interface by in vitro mutagenesis. J Biol Chem. 1997;272:24191–24197
  26. Marfatia SM, Leu RA, Branton D, et al.  Identification of the protein 4.1 binding interface on glycophorin C and p55, a homologue of the Drosophila discs-large tumor suppressor protein. J Biol Chem. 1995;270:715–719
  27. Anstee DJ, Ridgwell K, Tanner MJ, et al.  Individuals lacking the Gerbich blood-group antigen have alterations in the human erythrocyte membrane sialoglycoproteins beta and gamma. Biochem J. 1984;221:97–104
  28. Le Van Kim C, Colin Y, Mitjavila MT, et al.  Structure of the promoter region and tissue specificity of the human glycophorin C gene. J Biol Chem. 1989;264:20407–20414
  29. Colin Y. Gerbich blood groups and minor glycophorins of human erythrocytes. Transfus Clin Biol. 1995;2:259–268
  30. Reid ME, Anstee DJ, Jensen RH, et al.  Normal membrane function of abnormal beta-related erythrocyte sialoglycoproteins. Br J Haematol. 1987;67:467–472
  31. Chang S, Reid ME, Conboy J, et al.  Molecular characterization of erythrocyte glycophorin C variants. Blood. 1991;77:644–648
  32. Telen MJ, Le Van Kim C, Guizzo ML, et al.  Erythrocyte Webb-type glycophorin C variant lacks N-glycosylation due to an asparagine to serine substitution. Am J Hematol. 1991;37:51–52
  33. Telen MJ, Le Van Kim C, Chung A, et al.  Molecular basis for elliptocytosis associated with glycophorin C and D deficiency in the Leach phenotype. Blood. 1991;78:1603–1606
  34. Anstee DJ, Parsons SF, Ridgwell K, et al.  Two individuals with elliptocytic red cells apparently lack three minor erythrocyte membrane sialoglycoproteins. Biochem J. 1984;218:615–619
  35. Daniels GL, Shaw MA, Judson PA, et al.  A family demonstrating inheritance of the Leach phenotype (A Gerbich-negative phenotype associated with elliptocytosis). Vox Sang. 1986;50:117–121
  36. Nash GB, Parmar J, Reid ME. Effects of deficiencies of glycophorins C and D on the physical properties of the red cell. Br J Haematol. 1990;76:282–287
  37. Marfatia SM, Lue RA, Branton D, et al.  In vitro binding studies suggest a membrane-associated complex between erythroid p55, protein 4.1, and glycophorin C. J Biol Chem. 1994;269:8631–8634
  38. Dhermy D, Garbarz M, Lecomte MC, et al.  Hereditary elliptocytosis (Clinical, morphological and biochemical studies of 38 cases). Nouv Rev Fr Hematol. 1986;28:129–140
  39. Dalla VN, Gilsanz F, Alloisio N, et al.  Homozygous 4.1(−) hereditary elliptocytosis associated with a point mutation in the downstream initiation codon of protein 4.1 gene. J Clin Invest. 1992;90:1713–1717
  40. Vince JW, Reithmeier RA. Structure of the band 3 transmembrane domain. Cell Mol Biol (Noisy-le-grand). 1996;42:1041–1051
  41. Jay DG. Role of band 3 in homeostasis and cell shape. Cell. 1996;86:853–854
  42. Tanner MJA. The structure and function of band 3 (AE1) (Recent developments). Mol Membr Biol. 1997;14:155–165
  43. Popov M, Tam LY, Li J, et al.  Mapping the ends of transmembrane segments in a polytopic membrane protein. Scanning N-glycosylation mutagenesis of extracytosolic loops in the anion exchanger, band 3. J Biol Chem. 1997;272:18325–18332
  44. Bruce LJ, Anstee DJ, Spring FA, et al.  Band 3 Memphis variant II. Altered stilbene disulfonate binding and the Diego (Dia) blood group antigen are associated with the human erythrocyte band 3 mutation Pro854→Leu. J Biol Chem. 1994;269:16155–16158
  45. Bruce LJ, Ring SM, Anstee DJ, et al.  Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte band 3 (A site of interaction between band 3 and glycophorin A under certain conditions). Blood. 1995;85:541–547
  46. Harrison ML, Rathinavelu P, Arese P, et al.  Role of band 3 tyrosine phosphorylation in the regulation of erythrocyte glycolysis. J Biol Chem. 1991;266:4106–4111
  47. Jennings ML. Structure and function of the red blood cell anion transport protein. Annu Rev Biophys Biophys Chem. 1989;18:397–430
  48. Vince JW, Reithmeier RA. Carbonic anhydrase II binds to the carboxyl terminus of human band 3, the erythrocyte C1−/HCO3− exchanger. J Biol Chem. 1998;273:28430–28437
  49. Lux SE, Palek J. Disorders of the red cell membrane. In:  Handin RI,  Lux SE,  Stossel TP editor. Blood (Principles and Practice). Philadelphia, PA: Lippincott; 1995;p. 1701–1817
  50. Bruce LJ, Tanner MJA. Structure-function relationships of band 3 variants. Cell Mol Biol. 1996;42:953–973
  51. Delaunay J, Alloisio N, Morle L, et al.  Molecular genetics of hereditary elliptocytosis and hereditary spherocytosis. Ann Genet. 1996;39:209–221
  52. Hassoun H, Palek J. Hereditary spherocytosis (A review of the clinical and molecular aspects of the disease). Blood Rev. 1996;10:129–147
  53. Wang DN, Kuhlbrandt W, Sarabia VE, et al.  Two-dimensional structure of the membrane domain of human band 3, the anion transport protein of the erythrocyte membrane. EMBO J. 1993;12:2233–2239
  54. Hassoun H, Hanada T, Lutchman M, et al.  Complete deficiency of glycophorin A in red blood cells from mice with targeted inactivation of the band 3 (AE1) gene. Blood. 1998;91:2146–2151
  55. Peters LL, Shivdasani RA, Liu SC, et al.  Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell. 1996;86:917–927
  56. Inaba M, Yawata A, Koshino I, et al.  Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. J Clin Invest. 1996;97:1804–1817
  57. Liu SC, Zhai S, Palek J, et al.  Molecular defect of the band 3 protein in southeast Asian ovalocytosis. N Engl J Med. 1990;323:1530–1538
  58. Jarolim P, Palek J, Amato D, et al.  Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis. Proc Natl Acad Sci USA. 1991;88:11022–11026
  59. Mohandas N, Winardi R, Knowles D, et al.  Molecular basis for membrane rigidity of hereditary ovalocytosis (A novel mechanism involving the cytoplasmic domain of band 3). J Clin Invest. 1992;89:686–692
  60. Booth PB, Serjeantson S, Woodfield DG, et al.  Selective depression of blood group antigens associated with hereditary ovalocytosis among Melanesians. Vox Sang. 1977;32:99–110
  61. Sarabia VE, Casey JR, Reithmeier RA. Molecular characterization of the band 3 protein from Southeast Asian ovalocytes. J Biol Chem. 1993;268:10676–10680
  62. Moriyama R, Ideguchi H, Lombardo CR, et al.  Structural and functional characterization of band 3 from Southeast Asian ovalocytes. J Biol Chem. 1992;267:25792–25797
  63. Smythe JS, Spring FA, Gardner B, et al.  Monoclonal antibodies recognizing epitopes on the extracellular face and intracellular N-terminus of the human erythrocyte anion transporter (band 3) and their application to the analysis of South East Asian ovalocytes. Blood. 1995;85:2929–2936
  64. Bruce LJ, Ring SM, Ridgwell K, et al.  South-east Asian Ovalocytic (SAO) erythrocytes have a cold sensitive cation leak (Implications for studies of in vitro invasion of stored SAO red cells by Plasmodium falciparum malarial parasites). Blood. 1995;86:470a; (suppl 1, abstr)
  65. Karet FE, Gainza FJ, Györy AZ, et al.  Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci USA. 1998;95:6337–6342
  66. Bruce LJ, Tanner MJ. Erythroid band 3 variants and disease. Baillieres Best Pract Res Clin Haematol. 1999;12:637–654
  67. Bruce LJ, Unwin RJ, Wrong O, et al.  The association between familial distal renal tubular acidosis and mutations in the red cell anion exchanger (band 3, AE1) gene. Biochem Cell Biol. 1998;76:723–728
  68. Tanphaichitr VS, Sumboonnanonda A, Ideguchi H, et al.  Novel AE1 mutations in recessive distal renal tubular acidosis—Loss-of-function is rescued by glycophorin A. J Clin Invest. 1998;102:2173–2179
  69. Jarolim P, Shayakul C, Prabakaran D, et al.  Autosomal dominant distal renal tubular acidosis is associated in three families with heterozygosity for the R589H mutation in the AE1 (band 3) Cl−/HCO3− exchanger. J Biol Chem. 1998;273:6380–6388
  70. Bruce LJ, Cope DL, Jones GK, et al.  Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest. 1997;100:1693–1707
  71. Waugh SM, Low PS. Hemichrome binding to band 3 (Nucleation of Heinz bodies on the erythrocyte membrane). Biochemistry. 1985;24:34–39
  72. Seah TG, Lew TW, Chin NM. A case of pseudohyperkalaemia and thrombocytosis. Ann Acad Med Singapore. 1998;27:442–443
  73. Low PS. Structure and function of the cytoplasmic domain of band 3 (Center of erythrocyte membrane-peripheral protein interactions). Biochim Biophys Acta. 1986;864:145–167
  74. Rettig MP, Low PS, Gimm JA, et al.  Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog. Blood. 1999;93:376–384
  75. Beppu M, Ando K, Kikugawa K. Poly-N-acetyllactosaminyl saccharide chains of band 3 as determinants for anti-band 3 autoantibody binding to senescent and oxidized erythrocytes. Cell Mol Biol (Noisy-le-grand). 1996;42:1007–1024
  76. Kay MM. Mechanism of removal of senescent cells by human macrophages in situ. Proc Natl Acad Sci USA. 1975;72:3521–3525
  77. Ando K, Kikugawa K, Beppu M. Involvement of sialylated poly-N-acetyllactosaminyl sugar chains of band 3 glycoprotein on senescent erythrocytes in anti-band 3 autoantibody binding. J Biol Chem. 1994;269:19394–19398
  78. Ando K, Kikugawa K, Beppu M. Induction of band 3 aggregation in erythrocytes results in anti-band 3 autoantibody binding to the carbohydrate epitopes of band 3. Arch Biochem Biophys. 1997;339:250–257
  79. Schlüter K, Drenckhahn D. Co-clustering of denatured hemoglobin with band 3 (its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes). Proc Natl Acad Sci USA. 1986;83:6137–6141
  80. Kannan R, Labotka R, Low PS. Isolation and characterization of the hemichrome-stabilized membrane protein aggregates from sickle erythrocytes. Major site of autologous antibody binding. J Biol Chem. 1988;263:13766–13773
  81. Turrini F, Mannu F, Arese P, et al.  Characterization of the autologous antibodies that opsonize erythrocytes with clustered integral membrane proteins. Blood. 1993;81:3146–3152
  82. Hornig R, Lutz HU. Band 3 protein clustering on human erythrocytes promotes binding of naturally occurring anti-band 3 and anti-spectrin antibodies. Exp Gerontol. 2000;35:1025–1044
  83. Winograd E, Greenan JR, Sherman IW. Expression of senescent antigen on erythrocytes infected with a knobby variant of the human malaria parasite Plasmodium falciparum. Proc Natl Acad Sci USA. 1987;84:1931–1935
  84. Giribaldi G, Ulliers D, Mannu F, et al.  Growth of Plasmodium falciparum induces stage-dependent haemichrome formation, oxidative aggregation of band 3, membrane deposition of complement and antibodies, and phagocytosis of parasitized erythrocytes. Br J Haematol. 2001;113:492–499
  85. Ho M, Chelly J, Carter N, et al.  Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell. 1994;77:869–880
  86. Amara SG, Kuhar MJ. Neurotransmitter transporters (Recent progress). Ann Rev Neurosci. 1993;16:73–93
  87. Khamlichi S, Bailly P, Blanchard D, et al.  Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. Eur J Biochem. 1995;228:931–934
  88. Russo D, Redman C, Lee S. Association of XK and Kell blood group proteins. J Biol Chem. 1998;273:13950–13956
  89. Symmans WA, Shepherd CS, Marsh WL, et al.  Hereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system. Br J Haematol. 1979;42:575–583
  90. Taswell HF, Lewis JC, Marsh WL, et al.  Erythrocyte morphology in genetic defects of the Rh and Kell blood group systems. Mayo Clin Proc. 1977;52:157–159
  91. Wimer BM, Marsh WL, Taswell HF, et al.  Haematological changes associated with the McLeod phenotype of the Kell blood group system. Br J Haematol. 1977;36:219–224
  92. Redman CM, Huima T, Robbins E, et al.  Effect of phosphatidylserine on the shape of McLeod red cell acanthocytes. Blood. 1989;74:1826–1835
  93. Danek A, Uttner I, Vogl T, et al.  Cerebral involvement in McLeod syndrome. Neurology. 1994;44:117–120
  94. Marsh WL, Marsh NJ, Moore A, et al.  Elevated serum creatine phosphokinase in subjects with McLeod syndrome. Vox Sang. 1981;40:403–411
  95. Malandrini A, Fabrizi GM, Truschi F, et al.  Atypical McLeod syndrome manifested as X-linked chorea-acanthocytosis, neuromyopathy and dilated cardiomyopathy (Report of a family). J Neurol Sci. 1994;124:89–94
  96. Takashima H, Sakai T, Iwashita H, et al.  A family of McLeod syndrome, masquerading as chorea-acanthocytosis. J Neurol Sci. 1994;124:56–60
  97. Jung HH, Hergersberg M, Kneifel S, et al.  McLeod syndrome (A novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings). Ann Neurol. 2001;49:384–392
  98. Kawakami T, Takiyama Y, Yoshioka T, et al.  A case of McLeod syndrome with unusually severe myopathy. J Neurol Sci. 1999;166:36–39
  99. Alper SL, Kopito RR, Libresco SM, et al.  Cloning and characterization of a murine band 3-related cDNA from kidney and from a lymphoid cell line. J Biol Chem. 1988;263:17092–17099
  100. Bruce LJ, Kay MM, Lawrence C, et al.  Band 3 HT, a human red-cell variant associated with acanthocytosis and increased anion transport, carries the mutation Pro-868→Leu in the membrane domain of band 3. Biochem J. 1993;293:317–320
  101. Marsh WL, Redman CM. Recent developments in the Kell blood group system. Transfus Med Rev. 1987;1:4–20
  102. Redman CM, Marsh WL. The Kell blood group system and the McLeod phenotype. Semin Hematol. 1993;30:209–218
  103. Sorrentino G, De Renzo A, Miniello S, et al.  Late appearance of acanthocytes during the course of chorea-acanthocytosis. J Neurol Sci. 1999;163:175–178
  104. Hardie RJ. Acanthocytosis and neurological impairment—A review. Q J Med. 1989;71:291–306
  105. Swash M, Schwartz MS, Carter ND, et al.  Benign X-linked myopathy with acanthocytes (McLeod syndrome). Its relationship to X-linked muscular dystrophy. Brain. 1983;106:717–733
  106. Barnett MH, Yang F, Iland H, et al.  Unusual muscle pathology in McLeod syndrome. J Neurol Neurosurg Psychiatry. 2000;69:655–657
  107. Lee S, Russo D, Redman CM. The Kell blood group system (Kell and XK membrane proteins). Semin Hematol. 2000;37:113–121
  108. Redman CM, Russo D, Lee S. Kell, Kx and the McLeod syndrome. Baillieres Best Pract Res Clin Haematol. 1999;12:621–635
  109. Glaubensklee CS, Evan AP, Galey WR. Structural and biochemical analysis of the Mcleod erythrocyte membrane. I. Freeze fracture and discontinuous polyacrylamide gel electrophoresis analysis. Vox Sang. 1982;42:262–271
  110. Casey JR, Reithmeier RA. Analysis of the oligomeric state of band 3, the anion transport protein of the human erythrocyte membrane, by size exclusion high performance liquid chromatography. Oligomeric stability and origin of heterogeneity. J Biol Chem. 1991;266:15726–15737
  111. Jung HH, Russo D, Redman C, et al.  Kell and XK immunohistochemistry in McLeod myopathy. Muscle Nerve. 2001;24:1346–1351
  112. Danek A, Rubio JP, Rampoldi L, et al.  McLeod neuroacanthocytosis (Genotype and phenotype). Ann Neurol. 2001;50:755–764
  113. Avent ND, Reid ME. The Rh blood group system (A review). Blood. 2000;95:375–387
  114. Huang C-H, Liu PZ, Cheng JG. Molecular biology and genetics of the Rh blood group system. Semin Hematol. 2000;37:150–165
  115. Marini AM, Matassi G, Raynal V, et al.  The human rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast. Nature Genet. 2000;26:341–344
  116. Marini AM, Urrestarazu A, Beauwens R, et al.  The Rh (rhesus) blood group polypeptides are related to NH4+ transporters. Trends Biochem Sci. 1997;22:460–461
  117. Soupene E, Ramirez RM, Kustu S. Evidence that fungal MEP proteins mediate diffusion of the uncharged species NH(3) across the cytoplasmic membrane. Mol Cell Biol. 2001;21:5733–5741
  118. Huang CH, Liu PZ. New insights into the Rh superfamily of genes and proteins in erythroid cells and nonerythroid tissues. Blood Cells Mol Dis. 2001;27:90–101
  119. Westhoff CM, Ferreri-Jacobia M, Mak D-OD, et al.  Identification of the erythrocyte Rh blood group glycoprotein as a mammalian ammonium transporter. J Biol Chem. 2002;277:12499–12502
  120. Soupene E, King N, Feild E, et al.  Rhesus expression in a green alga is regulated by CO2. Proc Natl Acad Sci USA. 2002;99:7769–7773
  121. Seidl S, Spielmann W, Martin H. Two siblings with Rhnull disease. Vox Sang. 1972;23:182–189
  122. Ballas SK, Clark MR, Mohandas N, et al.  Red cell membrane and cation deficiency in Rh null syndrome. Blood. 1984;63:1046–1055
  123. Sturgeon P. Hematological observations on the anemia associated with blood type Rhnull. Blood. 1970;36:310–320
  124. Lauf PK, Joiner CH. Increased potassium transport and ouabain binding in human Rhnull red blood cells. Blood. 1976;48:457–468
  125. Heaton DC, McLoughlin K. Jk(a−b−) red blood cells resist urea lysis. Transfusion. 1982;22:70–71
  126. Olivès B, Mattei M-G, Huet M, et al.  Kidd blood group and urea transport function of human erythrocytes are carried by the same protein. J Biol Chem. 1995;270:15607–15610
  127. Olivès B, Neau P, Bailly P, et al.  Cloning and functional expression of a urea transporter from human bone marrow cells. J Biol Chem. 1994;269:31649–31652
  128. Macey RI, Yousef LW. Osmotic stability of red cells in renal circulation requires rapid urea transport. Am J Physiol. 1988;254:C669–C674
  129. Frohlich O, Macey RI, Edwards-Moulds J, et al.  Urea transport deficiency in Jk(a−b−) erythrocytes. Am J Physiol. 1991;260:C778–C783
  130. Sands JM, Gargus JJ, Frohlich O, et al.  Urinary concentrating ability in patients with Jk(a−b−) blood type who lack carrier-mediated urea transport. J Am Soc Nephrol. 1992;2:1689–1696
  131. Lucien N, Sidoux-Walter F, Olivès B, et al.  Characterization of the gene encoding the human Kidd blood group/urea transporter protein (Evidence for splice site mutations in Jknull individuals). J Biol Chem. 1998;273:12973–12980
  132. Irshaid NM, Henry SM, Olsson ML. Genomic characterization of the Kidd blood group gene (Different molecular basis of the Jk(a−b−) phenotype in Polynesians and Finns). Transfusion. 2000;40:69–74
  133. Zeidel ML, Ambudkar SV, Smith BL, et al.  Reconstitution of functional water channels in liposomes containing purified red cell CHIP28 protein. Biochemistry. 1992;31:7436–7440
  134. Nielsen S, Smith BL, Christensen EI, et al.  CHIP28 water channels are localized in constitutively water-permeable segments of the nephron. J Cell Biol. 1993;120:371–383
  135. Smith BL, Baumgarten R, Nielsen S, et al.  Concurrent expression of erythroid and renal aquaporin CHIP and appearance of water channel activity in perinatal rats. J Clin Invest. 1993;92:2035–2041
  136. Preston GM, Carroll TP, Guggino WB, et al.  Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. Science. 1992;256:385–387
  137. Preston GM, Agre P. Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons (Member of an ancient channel family). Proc Natl Acad Sci USA. 1991;88:11110–11114
  138. Sui H, Han BG, Lee JK, et al.  Structural basis of water-specific transport through the AQP1 water channel. Nature. 2001;414:872–878
  139. Preston GM, Smith BL, Zeidel ML, et al.  Mutations in aquaporin-1 in phenotypically normal humans without functional CHIP water channels. Science. 1994;265:1585–1587
  140. Cartron JP, Bailly P, Le Van Kim C, et al.  Insights into the structure and function of membrane polypeptides carrying blood group antigens. Vox Sang. 1998;74(suppl 2):29–64
  141. King LS, Choi M, Fernandez PC, et al.  Defective urinary-concentrating ability due to a complete deficiency of aquaporin-1. N Engl J Med. 2001;345:175–179
  142. King LS, Nielsen S, Agre P, et al.  Decreased pulmonary vascular permeability in aquaporin-1-null humans. Proc Natl Acad Sci USA. 2002;99:1059–1063
  143. Ma T, Yang B, Gillespie A, et al.  Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels. J Biol Chem. 1998;273:4296–4299
  144. Roudier N, Verbavatz JM, Maurel C, et al.  Evidence for the presence of aquaporin-3 in human red blood cells. J Biol Chem. 1998;273:8407–8412
  145. Ishibashi K, Sasaki S, Fushimi K, et al.  Molecular cloning and expression of a member of the aquaporin family with permeability to glycerol and urea in addition to water expressed at the basolateral membrane of kidney collecting duct cells. Proc Natl Acad Sci USA. 1994;91:6269–6273
  146. Daniels GL, Delong EN, Hare V, et al.  GIL (A red cell antigen of very high frequency). Immunohematology. 1998;14:49–52
  147. Roudier N, Ripoche P, Gane P, et al.  AQP3 deficiency in humans and the molecular basis of a novel blood group system, GIL. J Biol Chem. 2002;277:45854–45859
  148. Roudier N, Bailly P, Gane P, et al.  Erythroid expression and oligomeric state of the AQP3 protein. J Biol Chem. 2002;277:7664–7669
  149. Tournamille C, Le Van Kim C, Gane P, et al.  Molecular basis and PCR-DNA typing of the Fya/Fyb blood group polymorphism. Hum Genet. 1995;95:407–410
  150. Pogo AO, Chaudhuri A. The Duffy protein (A malarial and chemokine receptor). Semin Hematol. 2000;37:122–129
  151. Darbonne WC, Rice GC, Mohler MA, et al.  Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest. 1991;88:1362–1369
  152. Neote K, Darbonne W, Ogez J, et al.  Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem. 1993;268:12247–12249
  153. Horuk R, Colby TJ, Darbonne WC, et al.  The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor. Biochemistry. 1993;32:5733–5738
  154. Tournamille C, Filipe A, Wasniowska K, et al.  Structure/function analysis of the extracellular domains of the Duffy antigen/receptor for chemokines (Characterization of antibody and chemokine binding sites). Br J Haematol. 2003;122:1014–1023
  155. Chaudhuri A, Polyakova J, Zbrzezna V, et al.  Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci USA. 1993;90:10793–10797
  156. Miller LH, Mason SJ, Clyde DF, et al.  The resistance factor to Plasmodium vivax in blacks. The Duffy blood group genotype, FyFy. N Engl J Med. 1976;295:302
  157. Hadley TJ, Peiper SC. From malaria to chemokine receptor (The emerging physiologic role of the Duffy blood group antigen). Blood. 1997;89:3077–3091
  158. Hamblin MT, Di Rienzo A. Detection of the signature of natural selection in humans (Evidence from the Duffy blood group locus). Am J Hum Genet. 2000;66:1669–1679
  159. Tournamille C, Colin Y, Cartron JP, et al.  Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nature Genet. 1995;10:224–228
  160. Akalin E, Neylan JF. The influence of Duffy blood group on renal allograft outcome in African Americans. Transplantation. 2003;75:1496–1500
  161. Zimmerman PA, Woolley I, Masinde GL, et al.  Emergence of FY∗Anull in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Natl Acad Sci USA. 1999;96:13973–13977
  162. Mallinson G, Soo KS, Schall TJ, et al.  Mutations in the erythrocyte chemokine receptor (Duffy) geneThe molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a−b−) phenotype. Br J Haematol. 1995;90:823–829
  163. Rios M, Chaudhuri A, Mallinson G, et al.  New genotypes in Fy(a−b−) individuals (Nonsense mutations (Trp to stop) in the coding sequence of either FY A or FY B). Br J Haematol. 2000;108:448–454
  164. Luo H, Chaudhuri A, Zbrzezna V, et al.  Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol Cell Biol. 2000;20:3097–3101
  165. Dawson TC, Lentsch AB, Wang Z, et al.  Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood. 2000;96:1681–1684
  166. Abboud MR, Taylor EC, Habib D, et al.  Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol. 2000;111:482–490
  167. Jilma-Stohlawetz P, Homoncik M, Drucker C, et al.  Fy phenotype and gender determine plasma levels of monocyte chemotactic protein. Transfusion. 2001;41:378–381
  168. Parasol N, Reid M, Rios M, et al.  A novel mutation in the coding sequence of the FY∗B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phentoype. Blood. 1998;92:2237–2243
  169. Olsson ML, Smythe JS, Hansson C, et al.  The Fyx phenotype is associated with a missense mutation in the Fyb allele predicting Arg89Cys in the Duffy glycoprotein. Br J Haematol. 1998;103:1184–1191
  170. Tournamille C, Le Van Kim C, Gane P, et al.  Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fyx individuals. Blood. 1998;92:2147–2156
  171. Tournamille C, Le Van KC, Gane P, et al.  Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood. 1998;92:2147–2156
  172. Lee JS, Frevert CW, Wurfel MM, et al.  Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol. 2003;170:5244–5251
  173. Lee JS, Frevert CW, Thorning DR, et al.  Enhanced expression of Duffy antigen in the lungs during suppurative pneumonia. J Histochem Cytochem. 2003;51:159–166
  174. Irimura T, Tsuji T, Tagami S, et al.  Structure of a complex-type sugar chain of human glycophorin A. Biochemistry. 1981;20:560–566
  175. Gahmberg CG, Andersson LC. Role of sialic acid in the mobility of membrane proteins containing O-linked oligosaccharides on polyacrylamide gel electrophoresis in sodium dodecyl sulfate. Eur J Biochem. 1982;122:581–586
  176. Morrow B, Rubin CS. Biogenesis of glycophorin A in K562 human erythroleukemia cells. J Biol Chem. 1987;262:13812–13820
  177. Armitage IM, Shapiro DL, Furthmayr H, et al.  31P nuclear magnetic resonance evidence for polyphosphoinositide associated with the hydrophobic segment of glycophorin A. Biochemistry. 1977;16:1317–1320
  178. Mendelsohn R, Dluhy RA, Crawford T, et al.  Interaction of glycophorin with phosphatidylserine (A Fourier transform infrared investigation). Biochemistry. 1984;23:1498–1504
  179. Smith SO, Bormann BJ. Determination of helix-helix interactions in membranes by rotational resonance NMR. Proc Natl Acad Sci USA. 1995;92:488–491
  180. Brosig B, Langosch D. The dimerization motif of the glycophorin A transmembrane segment in membranes (Importance of glycine residues). Protein Sci. 1998;7:1052–1056
  181. MacKenzie KR, Prestegard JH, Engelman DM. A transmembrane helix dimer (Structure and implications). Science. 1997;276:131–133
  182. Poole J, Banks J, Bruce LJ, et al.  Glycophorin A mutation Ala65→Pro gives rise to a novel pair of MNS alleles ENEP (MNS39) and HAG (MNS41) and altered Wrb expression (Direct evidence for GPA/band 3 interaction necessary for normal Wrb expression). Transfus Med. 1999;9:167–174
  183. Groves JD, Tanner MJ. Glycophorin A facilitates the expression of human band 3- mediated anion transport in Xenopus oocytes. J Biol Chem. 1992;267:22163–22170
  184. Chasis JA, Mohandas N, Shohet SB. Erythrocyte membrane rigidity induced by glycophorin A-ligand interaction. Evidence for a ligand-induced association between glycophorin A and skeletal proteins. J Clin Invest. 1985;75:1919–1926
  185. Chasis JA, Reid ME, Jensen RH, et al.  Signal transduction by glycophorin A (Role of extracellular and cytoplasmic domains in a modulatable process). J Cell Biol. 1988;107:1351–1357
  186. Andersson LC, Gahmberg CG, Teerenhovi L, et al.  Glycophorin A as a cell surface marker of early erythroid differentiation in acute leukemia. Int J Cancer. 1979;24:717–720
  187. Langlois RG, Bigbee WL, Kyoizumi S, et al.  Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors. Science. 1987;236:445–448
  188. Kyoizumi S, Nakamura N, Hakoda M, et al.  Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow sorter. Cancer Res. 1989;49:581–588
  189. Reid ME  Lomas-Francis CBlood Group . Antigen Facts Book. (ed 2). San Diego, CA: Academic Press; 2003;
  190. Telen MJ, Chasis JA. Relationship of the human erythrocyte Wrb antigen to an interaction between glycophorin A and band 3. Blood. 1990;76:842–848
  191. Knowles DW, Chasis JA, Evans EA, et al.  Cooperative action between band 3 and glycophorin A in human erythrocytes (Immobilization of band 3 induced by antibodies to glycophorin A). Biophys J. 1994;66:1726–1732
  192. Siebert PD, Fukuda M. Molecular cloning of a human glycophorin B cDNA (Nucleotide sequence and genomic relationship to glycophorin A). Proc Natl Acad Sci USA. 1987;84:6735–6739
  193. Rearden A, Magnet A, Kudo S, et al.  Glycophorin B and glycophorin E genes arose from the glycophorin A ancestral gene via two duplications during primate evolution. J Biol Chem. 1993;268:2260–2267
  194. Furthmayr H. Structural comparison of glycophorins and immunochemical analysis of genetic variants. Nature. 1978;271:519–524
  195. Rahuel C, Vinit MA, Lemarchandel V, et al.  Erythroid-specific activity of the glycophorin B promoter requires GATA-1 mediated displacement of a repressor. EMBO J. 1992;11:4095–4102
  196. Camara-Clayette V, Thomas D, Rahuel C, et al.  The repressor which binds the -75 GATA motif of the GPB promoter contains Ku70 as the DNA binding subunit. Nucleic Acids Res. 1999;27:1656–1663
  197. Tanner MJA, Anstee DJ, Judson PA. A carbohydrate-deficient membrane glycoprotein in human erythrocytes of phenotype S−s−. Biochem J. 1977;165:157–161
  198. Tokunaga E, Sasakawa S, Tamaka K, et al.  Two apparently healthy Japanese individuals of type MkMk have erythrocytes which lack both the blood group MN and Ss-active sialoglycoproteins. J Immunogenet. 1979;6:383–390
  199. Perkins M. Inhibitory effects of erythrocyte membrane proteins on the in vitro invasion of the human malarial parasite (Plasmodium falciparum) into its host cell. J Cell Biol. 1981;90:563–567
  200. Pasvol G, Jungery M, Weatherall DJ, et al.  Glycophorin as a possible receptor for Plasmodium falciparum. Lancet. 1982;2:947–950
  201. Dolan SA, Miller LH, Wellems TE. Evidence for a switching mechanism in the invasion of erythrocytes by Plasmodium falciparum. J Clin Invest. 1990;86:618–624
  202. Orlandi PA, Klotz FW, Haynes JD. A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2- 3)Gal- sequences of glycophorin A. J Cell Biol. 1992;116:901–909
  203. Dolan SA, Proctor JL, Alling DW, et al.  Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes. Mol Biochem Parasitol. 1994;64:55–63
  204. Tippett P, Storry JR, Walker PS, et al.  Glycophorin A-deficient red cells may have a weak expression of C4-bound Ch and Rg antigens. Immunohematology. 1996;12:4–7
  205. Tomita A, Radike EL, Parker CJ. Isolation of erythrocyte membrane inhibitor of reactive lysis type II. Identification as glycophorin A. J Immunol. 1993;151:3308–3323
  206. el Ouagari K, Teissie J, Benoist H. Glycophorin A protects K562 cells from natural killer cell attack. Role of oligosaccharides. J Biol Chem. 1995;270:26970–26975
  207. Weber GF, Ashkar S, Glimcher MJ, et al.  Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science. 1996;271:509–512
  208. Verfaillie CM, Benis A, Iida J, et al.  Adhesion of committed human hematopietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin (Cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor). Blood. 1994;84:1802–1811
  209. Gee B, Platt OS. CD44 may be a laminin receptor of normal and sickle erythrocytes. Blood. 1995.;86:137a; (suppl 1, abstr)
  210. Goodison S, Urquidi V, Tarin D. CD44 cell adhesion molecules. J Clin Pathol Mol Pathol. 1999;52:189–196
  211. Ristamaki R, Joensuu H, Lappalainen K, et al.  Elevated serum CD44 level is associated with unfavorable outcome in non-Hodgkin’s lymphoma. Blood. 1997;90:4039–4045
  212. Parsons SF, Jones J, Anstee DJ, et al.  A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44 and a unique blood group phenotype [In(a−b−), Co(a−b−)]. Blood. 1994;83:860–868
  213. Nunomura W, Takakuwa Y, Tokimitsu R, et al.  Regulation of CD44-protein 4.1 interaction by Ca2+ and calmodulin. Implications for modulation of CD44-ankyrin interaction. J Biol Chem. 1997;272:30322–30328
  214. Nunomura W, Takakuwa Y, Parra M, et al.  Ca(2+)-dependent and Ca(2+)-independent calmodulin binding sites in erythrocyte protein 4.1. Implications for regulation of protein 4.1 interactions with transmembrane proteins. J Biol Chem. 2000;275:6360–6367
  215. Williams AF, Barclay AN. The immunoglobulin superfamily—Domains for cell surface recognition. Ann Rev Immunol. 1988;6:381–405
  216. Barclay AN, Brown MH, Law SKA, et al.  Leucocyte Antigen Facts Book. ed 2. San Diego, CA: Academic Press; 1997;
  217. Parsons SF, Mallinson G, Judson PA, et al.  Evidence that the Lub blood group antigen is located on red cell membrane glycoproteins of 85 and 78 kd. Transfusion. 1987;27:61–63
  218. Parsons SF, Mallinson G, Daniels GL, et al.  Use of domain-deletion mutants to locate Lutheran blood group antigens to each of the five immunoglobulin superfamily domains of the Lutheran glycoproteinElucidation of the molecular basis of the Lua/Lub and the Aua/Aub polymorphisms. Blood. 1997;89:4219–4225
  219. Parsons SF, Mallinson G, Holmes CH, et al.  The Lutheran blood group glycoprotein, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver. Proc Natl Acad Sci USA. 1995;92:5496–5500
  220. Rahuel C, Kim CL, Mattei MG, et al.  A unique gene encodes spliceoforms of the B-cell adhesion molecule cell surface glycoprotein of epithelial cancer and of the Lutheran blood group glycoprotein. Blood. 1996;88:1865–1872
  221. El Nemer W, Rahuel C, Colin Y, et al.  Organization of the human LU gene and molecular basis of the Lua/Lub blood group polymorphism. Blood. 1997;89:4608–4616
  222. Udani M, Zen Q, Cottman M, et al.  Basal cell adhesion molecule Lutheran protein—The receptor critical for sickle cell adhesion to laminin. J Clin Invest. 1998;101:2550–2558
  223. Zen Q, Cottman M, Truskey G, et al.  Critical factors in basal cell adhesion molecule/Lutheran-mediated adhesion to laminin. J Biol Chem. 1999;274:728–734
  224. El Nemer W, Gane P, Colin Y, et al.  The Lutheran blood group glycoproteins, the erythroid receptors for laminin, are adhesion molecules. J Biol Chem. 1998;273:16686–16693
  225. Southcott MJG, Parsons SF, Anstee DJ, et al.  Lutheran glycoprotein, a cell adhesion molecule that binds laminin with high affinity, is expressed on late erythrocyte precursors and appears after band 3. Blood. 1997.;90:175b; (suppl 2, abstr)
  226. Moulson CL, Li C, Miner JH. Localization of Lutheran, a novel laminin receptor, in normal, knockout, and transgenic mice suggests an interaction with laminin α5 in vivo. Develop Dynam. 2001;222:101–114
  227. Kikkawa Y, Moulson CL, Virtanen I, et al.  Identification of the binding site for the Lutheran blood group glycoprotein on laminin alpha 5 through expression of chimeric laminin chains in vivo. J Biol Chem. 2002;277:44864–44869
  228. Bolcato-Bellemin AL, Lefebvre O, Arnold C, et al.  Laminin alpha 5 chain is required for intestinal smooth muscle development. Dev Biol. 2003;260:376–390
  229. Parsons SF, Lee G, Spring FA, et al.  Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind α5 chain-containing human laminin with high affinity. Blood. 2001;97:312–320
  230. Mallinson G, Green CA, Okubo Y, et al.  The molecular background of recessive Lu(a−b−) phenotype in a Japanese family. Transfus Med. 1997.;7:18; (suppl 1, abstr)
  231. Udden MM, Umeda M, Hirano Y, et al.  New abnormalities in the morphology, cell surface receptors, and electrolyte metabolism of In(Lu) erythrocytes. Blood. 1987;69:52–57
  232. Shaw MA, Leak MR, Daniels GL, et al.  The rare Lutheran blood group phenotype Lu(a−b−) (A genetic study). Ann Hum Genet. 1984;48:229–237
  233. Telen MJ. The Lutheran antigens and proteins affected by Lutheran regulatory genes. In:  Agre PC,  Cartron J-P editor. Protein Blood Group Antigens of the Human Red Cell (Structure, Function, and Clinical Significance). Baltimore, MD: Johns Hopkins University Press; 1992;p. 70–87
  234. Telen MJ, Eisenbarth GS, Haynes BF. Human erythrocyte antigens. Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene. J Clin Invest. 1983;71:1878–1886
  235. Bailly P, Hermand P, Callebaut I, et al.  The LW blood group glycoprotein is homologous to intercellular adhesion molecules. Proc Natl Acad Sci USA. 1994;91:5306–5310
  236. Bailly P, Tontti E, Hermand P, et al.  The red cell LW blood group protein is an intercellular adhesion molecule which binds to CD11/CD18 leukocyte integrins. Eur J Immunol. 1995;25:3316–3320
  237. Spring FA, Parsons SF, Ortlepp S, et al.  Intercellular adhesion molecule-4 binds α4β1 and αV-family integrins through novel integrin-binding mechanisms. Blood. 2001;98:458–466
  238. Southgate CD, Chishti AH, Mitchell B, et al.  Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton. Nature Genet. 1996;14:227–230
  239. Lee G, Spring FA, Parsons SF, et al.  Novel secreted isoform of adhesion molecule ICAM-4 (Potential regulator of membrane-associated ICAM-4 interactions). Blood. 2003;101:1790–1797
  240. Hermand P, Gane P, Huet M, et al.  Red cell ICAM-4 is a novel ligand for platelet-activated αiibβ3 integrin. J Biol Chem. 2003;278:4892–4898
  241. Spring FA, Persons SF, Orthepp S, et al.  Intercellular adhesion molecule-4 binds alpha(4)beta(1)-family integrins through novel integrin-binding mechanisms. Blood. 2001;98:458–466
  242. Hermand P, Le Pennec PY, Rouger P, et al.  Characterization of the gene encoding the human LW blood group protein in LW+ and LW− phenotypes. Blood. 1996;87:2962–2967
  243. Giles CM. The LW blood group (A review). Immunol Commun. 1980;9:225–242
  244. Kanekura T, Miyauchi T, Tashiro M, et al.  Basigin, a new member of the immunoglobulin superfamily (Genes in different mammalian species, glycosylation changes in the molecule from adult organs and possible variation in the N-terminal sequences). Cell Struct Funct. 1991;16:23–30
  245. Spring FA, Holmes CH, Simpson KL, et al.  The Oka blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX-47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissues. Eur J Immunol. 1997;27:891–897
  246. Kasinrerk W, Fiebiger E, Stefanova I, et al.  Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule. J Immunol. 1992;149:847–854
  247. Igakura T, Kadomatsu K, Kaname T, et al.  A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. Dev Biol. 1998;194:152–165
  248. Yuasa J, Toyama Y, Miyauchi T, et al.  Specific localization of the basigin protein in human testes from normal adults, normal juveniles, and patients with azoospermia. Andrologia. 2001;33:293–299
  249. Heller M, von der OM, Kleene R, et al.  The immunoglobulin-superfamily molecule basigin is a binding protein for oligomannosidic carbohydrates (An anti-idiotypic approach). J Neurochem. 2003;84:557–565
  250. Wagner FF, Poole J, Flegel WA. The Scianna antigens including Rd are expressed by ERMAP. Blood. 2003;101:752–757
  251. Xu H, Foltz L, Sha Y, et al.  Cloning and characterization of human erythroid membrane-associated protein, human ERMAP. Genomics. 2001;76:2–4
  252. Su YY, Gordon CT, Ye TZ, et al.  Human ERMAP (An erythroid adhesion/receptor transmembrane protein). Blood Cells Mol Dis. 2001;27:938–949
  253. Ellis NA, Ye TZ, Patton S, et al.  Cloning of PBDX, an MIC2-related gene that spans the pseudoautosomal boundary on chromosome Xp. Nature Genet. 1994;6:394–400
  254. Ellis NA, Tippett P, Petty A, et al.  PBDX is the XG blood group gene. Nature Genet. 1994;8:285–290
  255. Bernard G, Breittmayer JP, de Matteis M, et al.  Apoptosis of immature thymocytes mediated by E2/CD99. J Immunol. 1997;158:2543–2550
  256. Tippett P, Ellis NA. The Xg blood group system (A review). Transf Med Rev. 1998;12:233–257
  257. Angelisova P, Drbal K, Cerny J, et al.  Characterization of the human leukocyte GPI-anchored glycoprotein CDw108 and its relation to other similar molecules. Immunobiology. 1999;200:234–245
  258. Mudad R, Rao N, Angelisova P, et al.  Evidence of CDw108 membrane protein bears the JMH blood group antigen. Transfusion. 1995;35:566–570
  259. Lee S, Zambas E, Green ED, et al.  Organization of the gene encoding the human Kell blood group protein. Blood. 1995;85:1364–1370
  260. Lee S, Lin M, Mele A, et al.  Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood. 1999;94:1440–1450
  261. Lee S, Russo D, Redman C. Functional and structural aspects of the Kell blood group system. Transfus Med Rev. 2000;14:93–103
  262. Lee S, Wu X, Reid ME, et al.  Molecular basis of the Kell (K1) phenotype. Blood. 1995;85:912–916
  263. Rao N, Whitsett CF, Oxendine SM, et al.  Human erythrocyte acetylcholinesterase bears the Yta blood group antigen and is reduced or absent in the Yt(a−b−) phenotype. Blood. 1993;81:815–819
  264. Spring FA, Gardner B, Anstee DJ. Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase. Blood. 1992;80:2136–2141
  265. Bartels CF, Zelinski T, Lockridge O. Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism. Am J Hum Genet. 1993;52:928–936
  266. Koch-Nolte F, Haag F. Mono (ADP-ribosyl) transferases and related enzymes in animal tissues. In:  Haag F,  Koch-Nolte F editor. ADP Ribosylation in Animal Tissues (Structure, Function, and Biology of Mono (ADP-Ribosyl) Transferases and Related Enzymes). New York, NY: Plenum; 1997;p. 1–13
  267. Gubin AN, Njoroge JM, Wojda U, et al.  Identification of the Dombrock blood group glycoprotein as a polymorphic member of the ADP-ribosyltransferase gene family. Blood. 2000;96:2621–2627
  268. Reid ME. The Dombrock blood group system (A review). Transfusion. 2003;43:107–114
  269. Lublin DM, Kompelli S, Storry JR, et al.  Molecular basis of Cromer blood group antigens. Transfusion. 2000;40:208–213
  270. Storry JR, Sausais L, Roye-Hue K, et al.  GUTI (A new antigen in the Cromer blood group system). Transfusion. 2003;43:340–344
  271. Holmes CH, Simpson KL, Okada H, et al.  Complement regulatory proteins at the feto-maternal interface during human placental development (Distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55)). Eur J Immunol. 1992;22:1579–1585
  272. Nowicki B, Hart A, Coyne KE, et al.  Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr. adhesin in a model of a cell-cell interaction. J Exp Med. 1993;178:2115–2121
  273. Daniels G. Functional aspects of red cell antigens. Blood Rev. 1999;13:14–35
  274. Mossakowska D, Dodd I, Pindar W, et al.  Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35) (SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation). Eur J Immunol. 1999;29:1955–1965
  275. Seya T, Holers VM, Atkinson JP. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF). J Immunol. 1985;135:2661–2667
  276. Klickstein LB, Wong WW, Smith JA, et al.  Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins. J Exp Med. 1987;165:1095–1112
  277. Hourcade D, Liszewski MK, Krych-Goldberg M, et al.  Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1. Immunopharmacology. 2000;49:103–116
  278. Telen MJ, Green AM. The Inab phenotype (Characterization of the membrane protein and complement regulatory defect). Blood. 1989;74:437–441
  279. Tamasauskas D, Powell V, Schawalder A, et al.  Localization of Knops system antigens in the long homologous repeats (LHRs) of complement receptor 1. Transfusion. 2001;41:1397–1404
  280. Moulds JM, Moulds JJ, Brown M, et al.  Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens (Negative and weak reactions are caused by variable expression of CR1). Vox Sang. 1992;62:230–235
  281. Yoon SH, Fearon DT. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J Immunol. 1985;134:3332–3338
  282. Rao N, Ferguson DJ, Lee SF, et al.  Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol. 1991;146:3502–3507
  283. Ng YC, Schifferli JA, Walport MJ. Immune complexes and erythrocyte CR1 (complement receptor type 1) (Effect of CR1 numbers on binding and release reactions). Clin Exp Immunol. 1988;71:481–485
  284. Rowe JA, Moulds JM, Newbold CI, et al.  P-falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature. 1997;388:292–295
  285. Moulds JM. Association of blood group antigens with immunologically important proteins. In:  Garratty G editors. Immunobiology of Transfusion Medicine. New York, NY: Marcel Dekker; 1994;p. 273–297
  286. Rowe PC, McLean RH, Wood RA, et al.  Association of homozygous C4B deficiency with bacterial meningitis. J Infect Dis. 1989;160:448–451
  287. Poschmann A, Fischer K, Seidl S, et al.  ABH receptors and red cell survival in a “Bombay” blood. Immunofluorescence studies by phytohemagglutinins and Helix agglutinins. Vox Sang. 1974;27:338–346
  288. Greenwell P. Blood group antigens (Molecules seeking a function?). Glycoconj J. 1997;14:159–173
  289. Marcus DM, Cass LE. Glycosphingolipids with Lewis blood group activity (Uptake by human erythrocytes). Science. 1969;164:553–555
  290. Boren T, Falk P, Roth KA, et al.  Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science. 1993;262:1892–1895
  291. Ilver D, Arnqvist A, Ögren J, et al.  Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science. 1998;279:373–377
  292. Guruge JL, Falk PG, Lorenz RG, et al.  Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci USA. 1998;95:3925–3930
  293. Heneghan MA, McCarthy CF, Moran AP. Relationship of blood group determinants on Helicobacter pylori lipopolysaccharide with host Lewis phenotype and inflammatory response. Infect Immun. 2000;68:937–941
  294. Garratty G. Blood group antigens as tumor markers, parasitic/bacterial/viral receptors, and their association with immunologically important proteins. Immunol Invest. 1995;24:213–232
  295. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen (Cellular receptor for B19 parvovirus). Science. 1993;262:114–117
  296. Carper E, Kurtzman GJ. Human parvovirus B19 infection. Curr Opin Hematol. 1996;3:111–117
  297. Karlsson KA. Animal glycosphingolipids as membrane attachment sites for bacteria. Ann Rev Biochem. 1989;58:309–350
  298. Daniels GL, Levene C, Berrebi A, et al.  Human alloantibodies detecting a red cell antigen apparently identical to MER2. Vox Sang. 1988;55:161–164
  299. Telen MJ. Erythrocyte blood group antigens (Polymorphisms of functionally important molecules). Semin Hematol. 1996;33:302–314

PII: S0037-1963(04)00002-2

doi: 10.1053/j.seminhematol.2004.01.001

Seminars in Hematology
Volume 41, Issue 2 , Pages 93-117 , April 2004

Article Tools

* Image Usage & Resolution